Cerulean Pharma Inc. 4
4 · Cerulean Pharma Inc. · Filed Oct 31, 2014
Insider Transaction Report
Form 4
GUIFFRE CHRISTOPHERD T
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-10-29+50,300→ 242,457 totalExercise: $4.36Exp: 2024-10-28→ Common Stock (50,300 underlying)
Footnotes (1)
- [F1]This option was granted on October 29, 2014. The option vests as to 2.08333% of the underlying shares monthly through and including October 29, 2018.